Japan based Takeda Pharmaceutical Company Limited has announced that results from the primary endpoint analysis of ...
Tokyo headquartered Hitachi, Ltd. and Centre Leon Berard (CLB), a leading French Comprehensive Cancer Center in Lyon-Fra...
Olympus Corporation has announced its Corporate Strategy in central Tokyo. The announcement follows the company's e...
Japan based Takeda Pharmaceutical Company Limited has announced that it has entered into an agreement to divest a portfo...
FUJIFILM Corporation is pleased to announce that its “Rapid Tuberculosis Diagnostic Kit” has won the Good De...
A simple assay may benefit drug discovery for treating diabetes, Parkinson's, and Alzheimers disease, as well as studies...
Promethera Biosciences SA (Group), a global innovator in cell-based medicines and liver diseases, had announced the foun...
Chugai Pharmaceutical has announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Ap...
US headquartered Pandion Therapeutics, Inc., and Japan based Astellas Pharma Inc. have announced the signing of a Licens...
Lobsor Pharmaceuticals AB, a privately held Swedish company based in Uppsala, has announced the Japanese Patent Office h...
Japan headquartered Hitachi, Ltd., has announced that it has provided its advanced proton therapy system to Sibley Memor...
Biogen and Eisai, Co., Ltd. (Tokyo, Japan) has announced that, after consulting with the U.S. Food and Drug Administrati...
MIMS Group, Asia's largest multi-channel provider of drug information, medical communications, events management and mar...
Germany based Rentschler Biopharma SE, a world-class contract development and manufacturing organization (CDMO) for biop...
Japanese firm Takeda Pharmaceutical Company and US based COUR Pharmaceutical Development Company, Inc. have announ...
AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) have announced that the US Food and Drug Administration...
Avidity Science is pleased to announce it has completed its acquisition of Edstrom Japan Ltd. The acquisition furthers A...
Using the function of the individual's own immune system to combat cancer, this out-of-the-box concept was proposed by D...
Astellas Pharma Inc. has announced that subsidiaries of Astellas will transfer their marketing authorizations, trademark...
Takeda Pharmaceutical Company Limited has announced that it has entered into an agreement to divest a portfolio of selec...
Canon Medical Systems Corporation has announced the official opening of its Middle East Division in Canon Middle East Du...
Japanese major research-driven pharmaceutical company Shionogi & Co., Ltd. has announced that it has enter...
Fuzionaire Diagnostics, in partnership with Tokyo-based radiopharmaceutical company Japan Medical Isotope Technology Dev...
Pharma major Lupin has announced the receipt of GMP (Good Manufacturing Practice) Certificate from the Pharmaceutical an...
US based Viela Bio, Inc. and Japanese firm Mitsubishi Tanabe Pharma Corporation have announced a collaboration focused o...
Daiichi Sankyo Company, Limited has announced the launch of VANFLYTA® (quizartinib), an oral FLT3 inhibitor, in...
Gilead Sciences, Inc. has announced the New Drug Application (NDA) for filgotinib, an investigational, oral, select...
PHC Corporation and Kakehashi Corporation have signed a sales partnership agreement for the sale of &ldqu...
Bayer AG (Bayer), and RIKEN Innovation Co., Ltd. (RIKEN Innovation), have entered into a strategic collaboration agreeme...
Japan headquartered Shiseido Company, Limited has announced that Shiseido Americas Corporation, a subsidiary of Shiseido...
Established 48 years ago in Japan, Mik Japan Co., Ltd., a drugstore chain managing over 50 outlets, has opened Samu...
AI Medical Service Inc., one of the world's first real-time endoscopic artificial intelligence (AI) developers, has anno...
Rentschler Biopharma SE, a world-class contract development and manufacturing organization (CDMO) for biopharmaceuticals...
US based Prometheus Biosciences, Inc., a biopharmaceutical company committed to the discovery, development, and commerci...
Swedish pharma company Moberg Pharma AB has signed an exclusive license agreement with Taisho Pharmaceutical Co., Ltd fo...
MIMETAS, with its presence in the Netherlands, US and Japan, and Hubrecht Organoid Technologies (HUB), a not-for-profit ...
Japanese firm Eisai Co., Ltd. and Tokio Marine & Nichido Fire Insurance Co., Ltd. have announced that the companies ...
Eisai Co., Ltd. and FRONTEO, Inc. have launched the tumbling and falling prediction system Coroban to medical institutio...
AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced the appointme...
Noven Pharmaceutical has announced its decision to appoint Dr. Naruhito Higo as Chief Executive Officer effective O...
Eisai Co., Ltd. and Meiji Seika Pharma Co., Ltd. have announced the manufacturing and marketing approval in Japan for th...
Japanese firm Takeda Pharmaceutical Company Limited and Denmark based H. Lundbeck A/S jointly announced that the M...
Astellas Pharma Inc. and FibroGen, Inc. have announced that Japan's Ministry of Health, Labour and Welfare (MH...
Kao Corporation has been selected for inclusion in the 2019 Dow Jones Sustainability World Index (DJSI World) and Dow Jo...
Solasia Pharma KK has announced that the darinaparsin Phase 2 study patient registration has reached the targ...
Eisai and Merck have announced that the U.S. Food and Drug Administration (FDA) approved the combination of LENVIMA, the...
Japan headquartered Toyobo Co., Ltd. has productized a ribonucleic acid (RNA) analysis kit based on a novel system title...
Mitsubishi Tanabe Pharma Corporation and Daiichi Sankyo Company Limited have announced that they have concluded a licens...
Seattle Genetics, Inc. and Astellas Pharma Inc. have announced that the U.S. Food and Drug Administration (FDA) has...
Japanese firm Astellas Pharma and iota Biosciences, Inc. have announced a joint research and development agree...
Japan headquartered Eisai Co., Ltd. and US based Biogen Inc. have announced the decision to discontinue the Phase III cl...
Astellas Venture Management, LLC, a wholly-owned venture capital subsidiary of Japan based Astellas Pharma Inc., and US ...
Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced that the results from SAkuraStar Study were presented at the...
Daiichi Sankyo Company Limited has announced it has launched a new generic formulation of oxycodone hydrochloride hydrat...
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) has announced the submission of a New Drug Application...
Takeda Pharmaceutical Company Limited, on 6 Sep 2019, announced that the company is issuing a US recall for all doses of...
Eisai Co., Ltd. has launched Etak® Antimicrobial Wet Wipes (classified as miscellaneous goods) containing long-...
Beyond Next Ventures Inc. and DENSO Corporation have announced that they have established OPExPARK Inc., a carve-out to ...
Sumitomo Dainippon Pharma Co., Ltd. , a leading Japanese pharmaceutical company, and Roivant Sciences Ltd., a technology...
DEKRA, a European vehicle inspection , has CE certificate to Japan headquartered Sanyo Chemical Industries fo...
Tokyo headquartered Eisai Co., Ltd. has announced that it has entered into a business alliance agreement for exclusive d...
ASEAN is facing rapid population ageing. It is estimated that all ASEAN countries will become ageing society (more than ...
Japan headquartered Kyowa Kirin has announced that the U.S. Food and Drug Administration (FDA) has granted approval for ...
Invicro , a member of the Konica Minolta Group and a leading provider of biomarkers for imaging, core lab services and s...
Japan based pharmaceutical firm Eisai Co., Ltd. announced that it provides tanks to supply clean water for the neglected...
Cantargia AB and BioWa Inc. have signed an extension of the license agreement around the BioWa proprietary POTELLIGENTTe...
Atonarp, a Japan headquartered hi-tech molecular diagnostics company, has announced that it has raised $33 million&...
Luye Pharma Group has announced its submission of the clinical trials application for a new chemical drug, Ansofaxine Hy...
GSK has announced the submission of a Japanese New Drug Application (JNDA) to the Ministry of Health, Labour and Welfare...
Takeda Pharmaceutical Company Limited has submitted a New Drug Application (NDA) to the Ministry of Health, Labour and W...
The Biological Systems Engineering Lab at Hiroshima University, Japan has developed a new 3D printed prosthetic hand com...
Shimadzu Medical Systems, a subsidiary of Shimadzu Corporation Japan, is proud to announce that they have received FDA 5...
OssDsign AB (publ), the Swedish designer and manufacturer of innovative implants for bone regeneration, has filed for a ...
Eisai Co., Ltd. has announced that it refresh its SAHNE® CREAM (quasi-drug) which has been widely used as medic...
Japan based Astellas Pharma Inc. has announced dosing of the first patient in the SKYLIGHT 1™ Phase 3 pivotal tria...
POLA Chemical Industries, Inc. Frontier Research Center (FRC) of POLA ORBIS Holdings Inc. and one of the world's top res...
Daiichi Sankyo Company has announced that the U.S. Food and Drug Administration (FDA) approved TURALIO™(pexidartin...
Sosei Group Corporation has announced that it has entered into a strategic multi-target partnership with Takeda Pharmace...
Rakuten Medical, Inc., a clinical-stage, global biotechnology company developing precision-targeted cancer therapies bas...
Sysmex Corporation has obtained Japanese manufacturing and marketing approval for the OncoBEAM™ RAS CRC Kit, ...
Japanese firm Morimoto Pharma has revealed their new prefilled syringe product, the Morimoto S.A.F.E. Syringe ...
FUJIFILM Corporation has announced that it has completed the acquisition of Biogen (Denmark) Manufacturing ApS, a large-...
Marken, a US headquartered patient-centric supply chain organization, has announced the acquisition of PCX Interna...
Japan based pharma company Kyowa Kirin Co. and US headquartered AVEO Oncology announce that they have amended their lice...
Sun Pharmaceutical Industries Ltd. has announced that one of its wholly owned subsidiaries has filed an application for ...
Pfizer Japan Inc. and Takeda Pharmaceutical Company Limited have announced the termination of co-promotion for the rheum...
OncoImmunity AS has announced that it has been acquired by NEC Corporation, the renowned Japanese IT and network co...
In a study recently published in Advanced Biomedical Engineering, researchers at Okayama University in Japan report...
Japan based Astellas Pharma Inc. and US headquartered Seattle Genetics, Inc. have announced submission of a Bi...
Akebia Therapeutics, Inc. has announced that Mitsubishi Tanabe Pharma Corporation (MTPC), its development and comm...
Japanese pharmaceutical firm Eisai, and Merck & Co., Inc., Kenilworth, N.J., U.S.A., known as MSD outside th...
German pharma company Bayer, US based Bristol-Myers Squibb (BMS) Company and Japan headquartered Ono Pharmaceutical Co.,...
The Center for iPS Cell Research and Application (CiRA) at Kyoto University and Takeda Pharmaceutical Company Limited (&...
Japan headquartered Sosei Group Corporation has entered into a multi-target research collaboration and license agreement...
AB-Biotics announced that Kaneka Europe Holding Company has launched a voluntary takeover bid for 100% of the share capi...
Japan based pharmaceutical firm Eisai Co., Ltd. has announced that the Eisai Center for Genetics Guided Dementia Discove...
Researchers at Okayama University have developed an early gastric cancer endoscopic diagnosis system using artificial in...
PHC is launching Medicom-HRf, an integrated medical chart system for medical clinics, with the aim to strengthen communi...
CMIC Group, a pioneer and a leading CRO (Contract Research Organizations) in Japan, announced on 10 July 2019, that the ...
Japanese pharmaceutical firm Eisai Co.,Ltd. has announced that it has entered into a collaboration research agreement wi...
